Abstract
The Spanish Sleep Society in its clinical practice guideline on the use of MAD suggest considering treatment with this device in patients diagnosed with mild or moderate sleep apnea without indication of CPAP treatment.
Objective: To analyze the objective response of a mandibular advancement device (MAD) in patients with snoring or mild/moderate sleep apnea (OSA) without indication of treatment with CPAP.
Material and Methods: A prospective, protocolized study was conducted to evaluate the effectiveness of a MAD validated by the FDA (SomnoDent) in patients diagnosed with simple snoring or mild / moderate OSA by means of home respiratory polygraphy that allows the measurement of snoring through a microphone and with this, a more precise detection and analysis of quantity and intensity of snoring.
Results: We included 49 patients who underwent a baseline study and another 3 months after adjustment and adaptation with the MAD, with the same polygraph. In the cases with insufficient control, the progress was increased and subsequently a new polygraph was made. Polygraphic variables were analyzed before starting the treatment and after the final adjustment.
Conclusions: In our experience, MAD has proven to be an alternative in the treatment of snoring or mild / moderate OSA. The decrease in snoring time and intensity of snoring is lower in the group of moderate OSA in relation to the longer breathing time without apneas.
Footnotes
Cite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA4178.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2019